JPRN-jRCTs052210188进行中(未招募)2 期
A phase II study Investigating the efficacy and safety of polyglycolic acid sheet for the prevention of infectious complication after laparoscopic surgery for gastric cancer
Obama Kazutaka0 个研究点目标入组 210 人开始时间: 2022年3月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 85age old(—)
- 性别
- All
入选标准
- •1)Pathologically diagnosed gastric adenocarcinoma
- •2)Laparoscopic/Robotic distal gastrectomy or total gastrectomy was performed
- •3)Clinical Stage I - III
- •4)Aged 18 - 85 years
- •5)Male and Female
- •6)ECOG Performance Status (PS) 0-1
- •7)Written informed consent was obtained
排除标准
- •1)Distant metastasis, invasion to other organs, or spread to esophagus
- •2)Neoadjuvant chemotherapy
- •3)Past history of irradiation to upper abdomen
- •4)Past history of upper abdominal surgery
- •5)Combined surgery for other diseases other than cholecystectomy
- •6)Severe infectious disease or other comorbidities
- •7)Sever drug allergy
- •8)Immune-suppressing drug or steroid use
- •9)Peritoneal dialysis or Hemodialysis
- •10)Multiple antiplatelet/ anticoagulant drug use or warfarin use
- •11)Pregnancy or suspected pregnancy
研究者
相似试验
进行中(未招募)
不适用
PGL5001 Proof of Concept study in inflammatory endometriosisEUCTR2012-001219-22-PLPregLem S.A.
招募中
2 期
A Phase II Study to Investigate the Efficacy and Safety of Oral intake of Anamorelin in Patients After Total GastrectomyAfter Total GastrectomyJPRN-jRCTs041230012Bando Etsuro65
进行中(未招募)
1 期
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000015841EUCTR2016-005115-41-HUTransgene S.A.39
进行中(未招募)
1 期
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2016-005115-41-BETransgene S.A.44
进行中(未招募)
1 期
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2016-005115-41-DKTransgene S.A.39
